BCL2 and malignant colon neoplasm: miR-192-5p decreased the liver metastasis of colon cancer in an orthotopic mouse model of colon cancer through targeting the expression of several oncogenic genes, including anti-apoptotic BCL2, Wnt/β-catenin activator called zinc finger E-box binding homeobox 2 (ZEB2) and pro-angiogenic VEGFA [114].